NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE66792 Query DataSets for GSE66792
Status Public on Apr 01, 2015
Title Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages
Organism Homo sapiens
Experiment type Expression profiling by array
Summary BCR–ABL1+ precursor B-cell acute lymphoblastic leukemia (BCR– ABL1+ B-ALL) is an aggressive hematopoietic neoplasm characterized by a block in differentiation due in part to the somatic loss of transcription factors required for B-cell development. We hypothesized that overcoming this differentiation block by forcing cells to reprogram to the myeloid lineage would reduce the leukemogenicity of these cells. We found that primary human BCR–ABL1+ B-ALL cells could be induced to reprogram into macrophage-like cells by exposure to myeloid differentiation-promoting cytokines in vitro or by transient expression of the myeloid transcription factor C/EBPα or PU.1. The resultant cells were clonally related to the primary leukemic blasts but resembled normal macrophages in appearance, immunophenotype, gene expression, and function. Most importantly, these macrophage-like cells were unable to establish disease in xenograft hosts, indicating that lineage reprogramming eliminates the leukemogenicity of BCR–ABL1+ B-ALL cells, and suggesting a previously unidentified therapeutic strategy for this disease. Finally, we determined that myeloid reprogramming may occur to some degree in human patients by identifying primary CD14+ monocytes/ macrophages in BCR–ABL1+ B-ALL patient samples that possess the BCR–ABL1+ translocation and clonally recombined VDJ regions.
 
Overall design We obtained the expression profiles of 5 human B-ALL samples using Afymmetrix U133A2 microarrays. Blasts were either analyzed without culture, or cultured in the presence of myeloid cytokines and sorted into CD14+ and CD19+ populations.
 
Contributor(s) McClellan JS, Dove C
Citation(s) 25775523
Submission date Mar 11, 2015
Last update date Apr 01, 2015
Contact name Christopher Dove
Phone 6507368078
Organization name Stanford University
Department Institute for Stem Cell Biology and Regenerative Medicine
Lab Majeti
Street address Room 3005, 265 Campus Drive, 3rd Floor
City Stanford
State/province CA
ZIP/Postal code 94305
Country USA
 
Platforms (1)
GPL19883 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array [CDF: Broad GenePattern]
Samples (15)
GSM1632210 Patient SU079 input blasts
GSM1632211 Patient SU079 cultured blasts, CD19 sorted
GSM1632212 Patient SU079 cultured blasts, CD14 sorted
Relations
BioProject PRJNA277970

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE66792_RAW.tar 71.3 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap